Appili Therapeutics Inc
OTC:APLIF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Appili Therapeutics Inc
OTC:APLIF
|
CA |
|
China High Speed Transmission Equipment Group Co Ltd
F:BGR
|
KY |
|
A
|
AutoStore Holdings Ltd
F:1IG
|
NO |
|
B
|
Bank of Nova Scotia
F:BKN
|
CA |
|
T
|
Troax Group AB (publ)
F:5TOA
|
SE |
|
Manolete Partners PLC
F:2BE
|
UK |
Intrinsic Value
Is APLIF undervalued or overvalued?
See the intrinsic value estimate for 
Appili Therapeutics Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
APLIF looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with APLIF’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Appili Therapeutics Does
Appili Therapeutics, Inc. operates as a biopharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. The company is headquartered in Halifax, Nova Scotia. The company went IPO on 2019-06-25. The firm is advancing a diverse range of anti-infectives, including an FDA-approved ready-made suspension of metronidazole for the treatment of antimicrobial-resistant infections, a vaccine candidate to eliminate a serious biological weapon threat, and a topical antiparasitic for the treatment of a disfiguring disease.
- Headquarters
- Canada CA
- Employees
- 7
- IPO date
- Jun 25, 2019
Revenue & Expenses Breakdown
Appili Therapeutics Inc
Earnings Waterfall
Appili Therapeutics Inc
The intrinsic value for Appili Therapeutics Inc (APLIF) under the Base Case is hidden USD.
Compared with the current market price of 0.007 USD, the stock appears hidden.